NICE rebuffs PCTs’ call to help identify more areas for savings

By 2009-07-30T00:00:00

Andrew Dillon the chief executive of the National Institute for Health and Clinical Excellence has rejected calls to identify more drugs and treatments that should be used less - or not at all - ahead of NHS investment cuts.

The National Institute for Health and Clinical Excellence has rejected calls to identify more drugs and treatments that should be used less - or not at all - ahead of NHS investment cuts.

You need to be an HSJ subscriber to read more

HSJ

Subscribe to read the full article

With an HSJ subscription you’ll get access to:

  • Expert Briefing newsletters, covering nine topics and regions
  • Weekly Catch Up – a summary of the week’s most important stories
  • Unlimited access to hsj.co.uk
  • The HSJ app

Subscribe

to HSJ

Enquire about multi-user access